Kamada (KMDA) Short term Debt (2016 - 2026)
Kamada (KMDA) posted quarterly Short term Debt of $10.6 million for Q1 2026, down 2.26% year-on-year from $10.9 million in Q1 2025, and up 7.26% on a QoQ basis from $9.9 million in Q4 2025.
Kamada (KMDA) Short term Debt (2016 - 2026) Analysis & Trends
Kamada (KMDA) has reported Short term Debt for 11 consecutive years, with $10.6 million the latest figure, recorded in Q1 2026.
- Quarterly Short term Debt fell 2.26% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 2.26% YoY) and the FY2025 annual result came in at $9.9 million, down 2.53% from the prior year.
- Short term Debt climbed to $10.6 million in Q1 2026 per KMDA's latest filing, from $9.9 million in the prior quarter.
- Over the last five years, Short term Debt for KMDA reached as high as $29.7 million in Q4 2022 and fell as low as $25095.0 in Q3 2022.
- A 5-year average of $13.1 million and a median of $10.9 million in 2025 frame the typical range for Short term Debt.
- The largest YoY upside for Short term Debt was 63613.89% in 2023 against a maximum downside of 99.85% in 2023.
- Year by year, Short term Debt stood at $29.7 million in 2022, then sank by 49.52% to $15.0 million in 2023, then plunged by 32.11% to $10.2 million in 2024, then declined by 2.53% to $9.9 million in 2025, then rose by 7.26% to $10.6 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $10.6 million, $9.9 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64 Mn |
| Dec 31, 2025 | 9.92 Mn |
| Sep 30, 2025 | 10.59 Mn |
| Jun 30, 2025 | 9.85 Mn |
| Mar 31, 2025 | 10.89 Mn |
| Dec 31, 2024 | 10.18 Mn |
| Sep 30, 2024 | 9.48 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 15.99 Mn |
| Jun 30, 2023 | 25.08 Mn |
| Mar 31, 2023 | 29,414.00 |
| Dec 31, 2022 | 29.71 Mn |
| Sep 30, 2022 | 25,095.00 |
| Jun 30, 2022 | 20.12 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 17.99 Mn |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 61,000.00 |